Table 2 Comparisons of laboratory findings between survivors and non-survivors
Pre-ECMO | Total | Survivors | Non-survivors | P |
|---|---|---|---|---|
Variables, median | n = 42 (IQR) | n = 34 (IQR) | n = 8 (IQR) | |
Hemoglobin (g/dL) | 12.8 (10.6–15.3) | 13.2 (10.8–15.6) | 11.5 (8.0–12.6) | 0.098 |
Platelet count (cells/μL) | 199.5 (100.5–276.2) | 237 (132.0–287.2) | 79 (43.5–167.5) | 0.003* |
Activated PTT (s) | 43.3 (31.5–64.1) | 39.8 (30.8–50.0) | 91.7 (62.6–107.4) | 0.003* |
INR | 1.2 (1.1–1.4) | 1.1 (1.0–1.3) | 1.7 (1.7–2.5) | 0.002* |
ABGA | ||||
pH | 7.19 (7.01–7.31) | 7.24 (7.0–7.3) | 6.95 (6.83–7.06) | 0.002* |
PaO2 mmHg | 60.5 (51.1–77.2) | 60.5 (51.1–74.4) | 58.7 (39.5–88.1) | 0.144 |
PaCO2 mmHg | 47.0 (38.9–62.4) | 46.1 (38.5–59.0) | 60 (50.3–109.7) | 0.409 |
PaO2/FiO2 | 61.5 (49.7–81.7) | 63 (51.1–80.7) | 55.9 (35.0–83.8) | 0.686 |
BUN (mg/dL) | 15.7 (12.0–21.1) | 15.7 (11.0–19.9) | 16.8 (13.7–23.3) | 0.519 |
Creatinine (mg/dL) | 1.1 (0.8–1.3) | 1.0 (0.8–1.3) | 1.3 (0.8–1.9) | 0.125 |
Bilirubin (mg/dL) | 0.8 (0.4–1.6) | 0.8 (0.4–1.6) | 0.6 (0.2–1.8) | 0.647 |
Lactate (mmol/L) | 6.7 (2.6–11.5) | 5.7 (2.4–9.2) | 15.0 (12.5–18.4) | 0.001* |